Challenges for the new Cancer Drugs Fund.

Littlejohns, Peter; Weale, Albert; Kieslich, Katharina; Wilson, James; Rumbold, Benedict; Max, Catherine; Rid, Annette

Littlejohns, Peter; Weale, Albert; Kieslich, Katharina; Wilson, James; Rumbold, Benedict; Max, Catherine; Rid, Annette.

Afiliação

Littlejohns P; Department of Primary Care and Public Health Sciences, King's College London, London WC2R 2LS, UK.
Weale A; Department of Political Sciences, University College London, London, UK.
Kieslich K; Department of Primary Care and Public Health Sciences, King's College London, London WC2R 2LS, UK.
Wilson J; Department of Philosophy, University College London, London, UK.
Rumbold B; Department of Philosophy, University College London, London, UK.
Max C; Catherine Max Consulting, London, UK.
Rid A; Department of Social Science, Health & Medicine, King's College London, London WC2R 2LS, UK. Electronic address: annette.rid@kcl.ac.uk.

Lancet Oncol ; 17(4): 416-418, 2016 04.

Article em En | MEDLINE | ID: mdl-26948924

Assuntos

Antineoplásicos/economia; Administração Financeira; Humanos; Medicina Estatal; Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Administração Financeira / Antineoplásicos Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google